FDA Inspection 1056492 — Amicus Therpeutics, Inc.
The FDA completed an inspection of Amicus Therpeutics, Inc. on May 30, 2018 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 30, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cranbury, NJ (United States)
Additional Details
Sponsor, Contract Research Organization